Biolase stock forecast.
Predicting stocks of American companies using artificial intelligence systems for 2023 - 2026 years. Analytics, charts. ... We forecast stock performance using neural networks based on historical data. In our forecasting, we also use technical analysis tools and consider global geopolitical factors and news events. ... BIOLASE, Inc. 1.11 (Nov ...
Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ... The BIOLASE stock forecast for tomorrow is $ 1.153103, which would represent a 1.15% gain compared to the current price. In the next week, the price of BIOL is expected to increase by 5.97% and hit $ 1.208013. As far as the long-term BIOLASE stock forecast is concerned, here’s what our ...Real time Biolase (BIOL) stock price quote, stock graph, news & analysis. Nov 29, 2023 · BIOLASE (BIOL) Stock Forecast & Price Target $1.10 -0.05 (-4.35%) (As of 11/29/2023 ET) Compare Today's Range $1.10 $1.20 50-Day Range $1.10 $1.89 52-Week Range $1.07 $99.50 Volume 88,335 shs Average Volume 156,585 shs Market Capitalization $2.53 million P/E Ratio N/A Dividend Yield N/A Price Target $77.00
BIOLASE expects total revenue for the 2021 second quarter to be between $7.5M to $8.5M. Net loss for the first quarter was $6.9M, or $0.06 per share, compared to a net loss of $6M, or $0.19 per ...WebDec 1, 2023 · Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ...
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and …
Biolase -20%. TELA Bio -18%. Adaptive Biotechnologies -14%. S&P 500 Health Care ... Goldman Sachs channels Taylor Swift for its 2024 stock market forecast Today, 4:48 PM 3 Comments.WebBiolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...BIOLASE tomorrow. We’ve gathered insights from a variety of expert analysts and amalgamated them to present an integrated daily outlook for BIOLASE shares for the forthcoming month. The nature of short-term forecasts often leads to a decrease in precision, attributed to the myriad of elements at play in the volatile financial markets.Price Prediction BIOLASE price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.
What was Biolase Inc stock price yesterday? Biolase Inc stock price yesterday was $1.09. What is the PE ratio of Biolase Inc?
The average BIOLASE stock forecast 2028 represents a -25.15% decrease from the last price of $1.14999997615814. For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72.
The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.BIOLASE, Inc. (BIOL) is a global leader in dental lasers, trading on NasdaqCM. The stock price, news, quote and history of BIOLASE, Inc. (BIOL) are available on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, research reports and more. The Protalix BioTherapeutics Inc stock price gained 0.719% on the last trading day (Friday, 17th Nov 2023), rising from $1.39 to $1.40. During the last trading day the stock fluctuated 3.28% from a day low at $1.37 to a day high of $1.42. The price has been going up and down for this period, and there has been a -24.32% loss for the last 2 …The Theriva Biologics, Inc. stock price gained 5.10% on the last trading day (Friday, 17th Nov 2023), rising from $0.390 to $0.410. During the last trading day the stock fluctuated 15.38% from a day low at $0.390 to a day high of $0.450. The price has been going up and down for this period, and there has been a -6.43% loss for the last 2 weeks.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWebStock analysis for Biolase Inc (BIOL:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the ...Dec 1, 2023 · BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire Sep 18, 2023 8:30pm Find the latest Atlantic American Corporation (AAME) stock quote, history, news and other vital information to help you with your stock trading and investing.Net loss attributable to common stockholders for the quarter ended September 30, 2023 was $4.6 million, or $3.89 per share, compared to a net loss of $8.4 million, or $110.36 per share (as ...Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and …Title: Biolase Stock: A Promising Investment in the Dental Technology Industry. Introduction: Biolase Inc. (NASDAQ: BIOL) is a leading global dental technology company that specializes in developing, manufacturing, and marketing innovative laser systems for dental professionals. With a strong focus on improving patient outcomes and …
Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. $173.46 -0.20. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Find the latest ...WebBiolase Inc Stock (BIOL) Forecast Our site uses a custom algorithm based on Deep Learning that helps our users to decide if BIOL could be a good portfolio addition. These …
Based on 3 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is €0.25 with a high forecast of €0.36 and a low forecast of €0.09. The average price target represents a BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is $100, with a range of $40 to $200. The stock has a low revenue growth rate and a high EPS loss in the past year.BIOLASE Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BIOLASE INC historical stock prices and determine the direction of BIOLASE INC's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading.BIOLASE, Inc. (NASDAQ:BIOL) shares tumbled 35% to $1.04. Biolase filed for offering of units each consisting of one share of common stock, warrant to purchase one share of common stock.The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: …The forecast for beginning of April 8450. Maximum value 8638, while minimum 7660. Averaged FTSE value for month 8224. Value at the end 8149, change for April -3.56%. NIO Stock Forecast 2023, 2024, 2025. More Stock Forecasts... FTSE 100 predictions for May 2025. The forecast for beginning of May 8149. Maximum value …WebBiolase, Inc. BIOLNASDAQ BIOLNASDAQ 1.24USD +0.02 +1.64% At close at Nov 24, 13:47 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast …31 dic 2019 ... ... forecast period. ... exercisable to 1,800,000 shares of BIOLASE Common Stock, with an exercise price of $10.00 per share of BIOLASE common stock.
9 nov 2023 ... ... Forecast · 7 Day Forecast · Weather Radar · Watches and Warnings · School ... $. 483. $. 562. Deemed dividend on preferred stock. $. —. $. 217.
Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...
Get the latest BIOLASE, Inc. (BIOL) stock news and headlines to help you in your trading and investing decisions. ... Performance Outlook. Short Term. 2W - 6W. Mid Term. 6W - 9M. ... BIOLASE, Inc ...27 oct 2021 ... ... stock at this time. If a reverse stock split causes our stock price to exceed $1.00 per share, those institutional investors will be able to ...Find the latest Atlantic American Corporation (AAME) stock quote, history, news and other vital information to help you with your stock trading and investing.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...The BIOLASE stock prediction results are shown below and presented as a graph, table and text information. BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38. Today 200 Day Moving Average is the resistance level (15.93 $).Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Assertio Holdings Inc () Stock Market info Recommendations: Buy or sell Assertio Holdings stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Assertio Holdings share forecasts, stock quote and buy / sell signals below.According to present data Assertio Holdings's ASRT shares and potentially its market environment …21 sept 2023 ... Shares of Biolase saw signs of life in the stock market today. The ... Instead of waiting for its share price to climb, it has conducted a ...Real time Biolase (BIOL) stock price quote, stock graph, news & analysis.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Price Prediction BIOLASE price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions ...
A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The Workhorse stock price fell by -5.66% on the last day (Thursday, 30th Nov 2023) from $0.394 to $0.372.During the last trading day the stock fluctuated 14.38% from a day low at $0.363 to a day high of $0.415.The price has fallen in 5 of the last 10 days and is down by -9.34% for this period. Volume has increased on the last day by 569 …WebGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Instagram:https://instagram. pague segurointeractive brokers pro vs litetlt etf pricetop 3 most sold products in the world Dec 1, 2023 · BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire Sep 18, 2023 8:30pm is magnifi goodapex funding futures BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “company”), a global leader in dental lasers, has announced that it held a special meeting of its stockholders on July 20, 2023 where the company’s stockholders granted the board of directors the discretion to effect a reverse stock split of the company’s common stock at a ratio …12 nov 1992 ... Introduction of Biolase, including company profile, stock information, contact number, and company business introduction. stocks in spy BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12 BIOLASE, Inc. to Report Q2, 2022 Results on Aug 11, 2022BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12 BIOLASE, Inc. to Report Q2, 2022 Results on Aug 11, 2022